Neuromuscular blockade management in patients with COVID-19

This narrative review evaluates the evidence for using neuromuscular blocking agents (NMBA) in patients being treated for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). While large prospective randomized-controlled trials (RCTs) are lacking at this point in time, smaller observational...

Descripción completa

Detalles Bibliográficos
Autores principales: Chaves-Cardona, Harold, Hernandez-Torres, Vivian, Kiley, Sean, Renew, Johnathan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Anesthesiologists 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8342831/
https://www.ncbi.nlm.nih.gov/pubmed/33934595
http://dx.doi.org/10.4097/kja.21106

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8342831/
https://www.ncbi.nlm.nih.gov/pubmed/33934595
http://dx.doi.org/10.4097/kja.21106

Ejemplares similares